Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. 1997

A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.

Our earlier studies have shown that changes in serum corticosterone levels played an important role in the acquisition of sensitization to MK-801, a non-competitive NMDA receptor antagonist. Dopaminergic mechanisms are found to be particularly important in the development of sensitization; hence in the present study we assessed the binding of [3H]SCH 23390 at brain dopaminergic D1 receptors, after administration of MK-801 (0.4 mg/kg), in rats in which corticosterone synthesis was inhibited by metyrapone (150 + 50 mg/kg). Such metyrapone pretreatment prevented the increases in serum corticosterone level induced by MK-801. The binding studies, using receptor autoradiography, were performed in the following brain structures: the striatum, nucleus accumbens, olfactory tubercle and substantia nigra. Metyrapone per se did not change or slightly increased D1 receptor binding in the substantia nigra, while in other brain structures tested it decreased the number of these receptors by about 30%. MK-801 increased the level of D1 receptors in the nucleus accumbens core and olfactory tubercle, being without effect in the remaining brain structures tested. In rats which were pretreated with metyrapone, the effect of MK-801 on D1 receptors was inhibited in the nucleus accumbens core only. In substantia nigra, metyrapone provoked the MK-801-induced decrease in D1 receptors whereas in all other structures MK-801 reversed the effects of metyrapone on D1 receptors. Additionally, the effect of metyrapone and MK-801 on grooming behavior induced by D1 receptor agonist SKF 38393 (10 mg/kg) was tested. Metyrapone did not influence grooming induced by SKF 38393, but significantly potentiated the inhibitory effect of MK-801 on this behavior. Finally, we found that metyrapone did not influence the expression of the sensitization induced by MK-801. Our results seem not to support hypothesis that MK-801 evokes enhancement of dopaminergic neurotransmission (at the level of D1 receptors) via corticosterone liberation, since in most brain regions studied inhibition of increases in corticosterone level did not prevent MK-801-induced effects on D1 receptors. The present study may suggest that NMDA receptors are involved in the corticosterone-dependent regulation of the density of the D1 receptors.

UI MeSH Term Description Entries
D008297 Male Males
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D006120 Grooming An animal's cleaning and caring for the body surface. This includes preening, the cleaning and oiling of feathers with the bill or of hair with the tongue. Preening,Groomings,Preenings
D006948 Hyperkinesis Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders. Hyperactivity, Motor,Hyperkinesia,Hyperkinesia, Generalized,Hyperkinetic Movements,Generalized Hyperkinesia,Generalized Hyperkinesias,Hyperkinesias, Generalized,Hyperkinetic Movement,Motor Hyperactivity,Movement, Hyperkinetic,Movements, Hyperkinetic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.

Related Publications

A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
September 1993, Brain research,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
January 1993, Psychopharmacology,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
February 1995, Psychopharmacology,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
January 1998, European journal of pharmacology,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
January 1996, Brain research bulletin,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
September 1995, Brain research,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
January 1994, European journal of pharmacology,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
July 2000, Brain research,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
June 1996, Brain research,
A Czyrak, and M Maćkowiak, and K Fijał, and A Chocyk, and K Wedzony
August 1999, Psychopharmacology,
Copied contents to your clipboard!